F S&P 500
5,205.25 -7.50 (-0.14%) F Dow Jones
39,110.00 -85.00 (-0.22%) F Nasdaq
18,158.00 -28.50 (-0.16%) E-mini Russell 2000 Index Futur
2,059.80 -5.00 (-0.24%) Petróleo
79.50 +0.51 (+0.65%) Oro
2,325.30 +3.00 (+0.13%)
Alterola Biotech, Inc. (ABTI)
Alterola Biotech, Inc.
47 Hamilton Square
Birkenhead CH41 5AR
United Kingdom
44 1516 019 477
https://www.alterolabio.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Timothy Paul Rogers | Executive Chairman & CFO | N/D | N/D | 1964 |
| Mr. David John Hitchcock O.B.E. | CEO & Director | N/D | N/D | 1964 |
| Mr. Colin G. Stott B.Sc. | COO & Director | N/D | N/D | 1966 |
| Mr. Dominic Schiller | IP Counsel, Chief IP Officer & Director | N/D | N/D | 1965 |
Descripción
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. was founded in 2021 and is based in Birkenhead, the United Kingdom.
Gestión corporativa
La calificación ISS Governance QuickScore de Alterola Biotech, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
